Olivier Brandicourt - May 18, 2023 Form 4 Insider Report for ALNYLAM PHARMACEUTICALS, INC. (ALNY)

Role
Director
Signature
By: /s/ Stephen Hall, Attorney-in-Fact For: Olivier Brandicourt
Stock symbol
ALNY
Transactions as of
May 18, 2023
Transactions value $
$0
Form type
4
Date filed
5/19/2023, 04:06 PM
Previous filing
May 20, 2022
Next filing
Jan 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALNY Stock Option (right to buy) Award $0 +3.45K $0.00 3.45K May 18, 2023 Common Stock 3.45K $189.87 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney